HAVE you ever found yourself sitting at the blackjack table, palms slightly damp, cards upturned, a quiet tension in the air, ...

(“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced ...

Arms control talks with Russia may seem unlikely during the Ukraine War, but that is precisely why they are needed.

Palantir surges on AI demand, strong Q3 growth, and defense contracts. PLTR stock's Q3'25 revenue surged 63% YoY. Read here ...

Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a global provider of tech-enabled mobility solutions, today ...

Stock Repurchase: On October 3, 2025, GameSquare announced its initial stock repurchase under its previously announced $5 ...

Companies involved in spaceflight have been around since the start of the Space Age. By the 1980s, corporate space activity ...

Who is allowed to launch rockets and who is responsible for any damages? An overview of space law, national laws, and ...

At its foundation, Earn Matrix Pro combines machine learning, data modeling, and real-time analytics to automate trade ...

Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

The Company intends to appeal this determination to a Nasdaq hearings panel (a “Panel”), at which the Company plans to present a compliance plan to address the deficiencies relating to the Equity Rule ...